成長に支援が必要な小児におけるソマパシタン週1回投与とノルディトロピン®1日1回投与を比較する研究

基本情報

NCT ID

NCT05330325

ステータス

実施中（募集終了）

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

399

治験依頼者名

Novo Nordisk A/S

概要

The study compares two medicines for treatment of children born small and who stay small, or with Turner Syndrome, Noonan Syndrome, or idiopathic short stature. The purpose of the study is to see how well treatment with somapacitan works compared to treatment with Norditropin®. Somapacitan is a new medicine, and Norditropin® is a medicine doctors can already prescribe in some countries. The study will last for upto 5.5 years. The participants will either get somapacitan once a week up to 5.5 years or Norditropin® once a day for 1 year followed by somapacitan once a week for up to 4.5 years. Which treatment the participants get is decided by chance.

対象疾患

介入

依頼者（Sponsor）

実施施設 (19)